CMPI.org
MENU
CMPI
Drugwonks
The biggest challenge facing the FDA’s new Rare Disease Innovation Hub
Read More
Countries Not Paying Their Fair Share of the Cost of Biopharmaceutical Innovation - What Can the US Do to Change That?
  • RCJ
  • 05/09/2025 12:00 AM

Countries Not Paying Their Fair Share of the Cost of Biopharmaceutical Innovation - What Can the US Do to Change That?

The principal reason for the disparity in biopharmaceutical pricing is that governments in other developed countries use ...  Read more

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Differing philosophies within and outside of government could doom the hub...  Read more

White Paper: Expanding Access to Pneumonia Vaccines — A Vital Public Health Measure

White Paper: Expanding Access to Pneumonia Vaccines — A Vital Public Health Measure

...  Read more

Read all News

CMPI

The Center for Medicine in the Public Interest is a nonprofit, nonpartisan research and educational organization that seeks to advance the discussion and development of patient-centered health care.

SUBSCRIBE

JOIN CMPI

Like CMPI on Facebook
Follow CMPI on Twitter
Connect with CMPI on LinkedIn
Watch our Videos on CMPI YouTube Channel
Subscribe to Receive CMPI RSS Feeds

EVENTS

3D Printing Summit View Event
The Hilton at Short Hills
11/08/2018 12:00 AM | 8:00 am - 3:00 pm
Principles for Patient-Centered Prescription Drug Coverage View Event
National Press Club in Washington, D.C.
09/11/2017 12:00 AM | 8:30 AM
Capitol Hill Briefing: Personalized Medicine and Responsible Access to Pain Medication View Event
Personalized Medicine and Responsible Access to Pain Medication
09/10/2013 12:00 AM | 8:00 PM
PDUFA without the Politics View Event
Rayburn House Office Building
“Defining the Future of the FDA: PDUFA V and Beyond.”
11/29/2011 12:00 AM | 12pm
CMPI 3rd Annual Odyssey Gala View Event
Trump Soho
Honoring Mitch Daniels, Paul Offit, M.D., & Montel Williams
10/05/2011 12:00 AM | 6pm
View All Events

COMMENTARY

Read All Commentary

DRUGWONKS BLOG

A Kick-Back by Any Other Name CVS Plan to Use ICER To Screw Patients Elicits Silence From HHS and Health Media (Out of) Pocket Change John Arnold: ICER Can Make PBMs Great Again Bloomberg’s Max Nisen: CVS Should Use ICER Pricing to Exclude Drugs for Sickest Patients Peter" Bachs" Dying PBM Business Model Outbreak of Foot-in-Mouth Disease at HHS Healthcare's High Stakes Exam Gray Lady Misses the Mark on the 21st Century FDA PBM Transparency Legislation? How's Bayou?
Read All of Drugwonks

VIDEOS & INTERVIEWS

Watch All
Peter Pitts on CNBC
Peter Pitts on CNBC
Bob Goldberg on Fox Business News
Bob Goldberg on Fox Business News
Paul Offit at Third Annual Odyssey Awards
Paul Offit at Third Annual Odyssey Awards
Montel Williams at Third Annual Odyssey Awards
Montel Williams at Third Annual Odyssey Awards
Senator John Barrasso, M.D. (R-WY) on health care reform
Senator John Barrasso, M.D. (R-WY) on health care reform
Congressman Paul Ryan (R-WI) on health care reform
Congressman Paul Ryan (R-WI) on health care reform
Just Say No To Vaccines (PSA)
Just Say No To Vaccines (PSA)
Science or Celebrity
Science or Celebrity

Reports

Research Issues

Expanding Access to Pneumonia Vaccines — A Vital Public Health Measure
October 2024
Truth vs. Tort
July 2024
340B and the Warped Rhetoric of Healthcare Compassion
September 2022
The Spreading Cancer of Counterfeit Drugs
October 2020
AARP's Stop Rx Greed Campaign Should Focus on AARP's Rx Greed
January 2020
Restoring the Balance Between Innovation and Generic Manufacturing of Medicines
April 2019
Read All Reports
Biosimilars
Cure Strategy
Opioids
Personalized Medicine
Price Controls
Safe Drug Use
Tabloid Medicine
The Truth about Drug Pricing
Value of Medical Innovation
Value-Based Reimbursement